Although alternatively activated microglia/macrophages have been attributed a relevant role as immune response regulators that produce anti-inflammatory cytokines such as IL-10, IL-4, and IL-13 [132], it remains unclear how they might enter this activation state and influence lesion development in MS tissue. Here, IL4 is linked to myeloid sarcoma.